Skip to main content
. Author manuscript; available in PMC: 2020 Feb 1.
Published in final edited form as: Clin Cancer Res. 2018 Dec 18;25(3):937–945. doi: 10.1158/1078-0432.CCR-18-1927

Table 3.

Most frequent AEs, regardless of relationship to any drugs

Most frequent events (occurring in ≥ 10% patients) Cohort 1(%)
n =12
Phase II (%)
n = 35a
All
n = 41)
Hypoalbuminemia 12 (100) 32 (91) 38 (93)
Anemia 12 (100) 32 (91) 38 (93)
Alkaline phosphatase increased 12 (100) 31 (89) 37 (88)
Thrombocytopenia 10 (83) 30 (86) 36 (88)
Aspartate aminotransferase increased 7 (57) 28 (80) 31 (76)
Rash acneiform 8 (67) 19 (54) 27 (66)